Ovarian Cancer Screening and AI
Many specialist doctors who treat women (gynaecologists) might think ovarian cancer screening is more helpful and safer than it truly is. This study wants to see if using a special computer program, or AI, can help correct these ideas. We're testing if an AI conversation that shares clear, fact-based information about ovarian cancer screening can help gynaecologists understand the real benefits and risks better. This could lead to them making more accurate recommendations for women, compared to just having a general AI chat about how common ovarian cancer is. The goal is to make sure women get the most accurate and helpful advice possible.
De un vistazo
¿De qué trata este estudio?
This study is all about making sure women get the best and most accurate advice about screening for ovarian cancer. It's been found that gynaecologists, who are specialist doctors for women's health, sometimes believe that ovarian cancer screening is more effective and safer than scientific evidence suggests. This can lead to women getting tests they might not actually need, which can cause unnecessary worry or even other problems.
Researchers are now exploring whether a type of computer programme called Artificial Intelligence (AI) can help. They are testing if an AI tool that talks to gynaecologists about ovarian cancer screening – explaining the facts and clearing up any misunderstandings – can improve the doctors' knowledge. The hope is that by giving gynaecologists better information, they will revise their advice and recommendations to patients, focusing on what the science truly shows.
Essentially, the study randomly divides gynaecologists into two groups. One group talks with an AI that specifically discusses the evidence around screening benefits and harms. The other group has a general chat with AI about how often ovarian cancer occurs. By comparing the recommendations made by doctors in both groups before and after their AI chat, the researchers will see if the AI discussion made a difference in how gynaecologists advise their patients.
Puntos clave
- The study aims to improve doctors’ understanding of ovarian cancer screening.
- It uses AI conversations to help doctors learn about the true benefits and risks.
- The goal is for doctors to give more accurate, evidence-based advice to women.
- No patients are directly involved in medical tests as part of this study.
- This research focuses on improving healthcare communication and reducing unnecessary procedures.
¿Quién puede ser elegible?
This study is looking for women's health doctors, called gynaecologists, who work in clinics and regularly suggest ovarian cancer screening (like a special ultrasound or blood test called CA 125) to their patients. These are patients who don't have any symptoms and aren't at higher risk than average.
To be clear, the study is specifically looking for gynaecologists whose current practice of recommending screening to these women goes against general medical advice for people without symptoms or specific risk factors.
Doctors who work in hospitals (inpatient care) or gynaecologists who do not usually recommend ovarian cancer screening to average-risk patients without symptoms are not eligible to take part in this study.
¿Podría este estudio ser adecuado para ti?
Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.
- Are you a gynaecologist (women's health doctor)?
- Do you work in an outpatient clinic (not a hospital ward)?
- Do you currently recommend ovarian cancer screening (like ultrasound or CA 125 test) to women who don't have symptoms and aren't at high risk?
- Are your patients generally at 'average risk' for ovarian cancer, meaning no strong family history or known genetic risks?
¿En qué consiste la participación?
This study doesn't involve any medical procedures, medication, or follow-up appointments for patients. It's focused on understanding how doctors give advice. If you were a gynaecologist taking part, you would first answer some questions about your current understanding of ovarian cancer screening and what advice you usually give. Then, you'd have a conversation with an AI program. After the AI chat, you'd answer similar questions again to see if your understanding or advice has changed. The total time commitment for a gynaecologist participating in this study would be quite short, likely just one session.
Riesgos y beneficios potenciales
Ubicaciones (1)
- Charité - Universitätsmedizin BerlinCódigo postal verificadoMitte, Germany
Preguntas comunes
What is ovarian cancer screening?
Ovarian cancer screening usually involves tests like a special ultrasound scan of the ovaries or a blood test called CA 125. The aim is to try and find cancer early in people who don't have any symptoms.
Is ovarian cancer screening recommended for all women?
No, for women who don't have symptoms and are at average risk (meaning no strong family history or genetic risks), routine ovarian cancer screening is generally not recommended by medical guidelines because it hasn't been shown to save lives overall and can sometimes lead to unnecessary worry or procedures.
¿Qué es la IA?
AI stands for Artificial Intelligence. It's a computer program designed to think and learn, and in this study, it's used to have conversations and share information.
¿Por qué es importante este estudio?
This study is important because it wants to make sure that doctors have the most up-to-date and accurate information about ovarian cancer screening. This helps them give the best possible advice to their patients, avoiding unnecessary tests or worries.
¿Quién puede participar en este estudio?
This study is for gynaecologists (women's health doctors) who regularly recommend ovarian cancer screening to their patients who do not have symptoms and are at average risk.
Cómo obtener más información
Odette Wegwarth, Prof. Dr.
Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.
¿Interesado en participar?
Discusión
Discusión comunitaria
Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.